• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低胎盘生长因子水平和高可溶性内皮糖蛋白水平在妊娠 26-31 周时分别预示着轻胎盘和伴有相对较重婴儿的轻胎盘:一项回顾性队列研究。

Low placental growth factor levels and high soluble endoglin levels at 26-31 weeks of gestation precede light placenta with and without relatively heavy infant, respectively: A retrospective cohort study.

机构信息

Department of Obstetrics and Gynecology, Jichi Medical University School of Medicine, Tochigi, Japan.

Department of Food and Health Sciences, Jissen Women's University, Tokyo, Japan.

出版信息

J Obstet Gynaecol Res. 2021 Mar;47(3):1040-1051. doi: 10.1111/jog.14636. Epub 2021 Jan 5.

DOI:10.1111/jog.14636
PMID:33401341
Abstract

AIM

Our aim was to examine whether serum levels of placental growth factor (PlGF) and soluble endoglin (sEng) at 19-25 and 26-31 weeks of gestation were associated with the occurrence of the 9-block categorization of placenta weight (PW) and fetal/placenta ratio (F/P ratio).

METHODS

We performed a retrospective cohort study in 1391 women with singleton pregnancy. Serum levels of PlGF and sEng were measured by enzyme immunosorbent assay. A light placenta was defined as PW ZS < -1.28 SD. Based on the PW (light, normal, and heavy) and F/P ratio (relatively heavy, balanced growth, and relatively small), 9-block categorization were performed. Multivariable logistic regression analyses were performed.

RESULTS

Low PlGF at 26-31 weeks was an independent risk factor for the birth of infants belonging to Block A (light placenta and relatively heavy infant), after adjusting for prepregnancy body mass index and serum levels of sEng. High sEng at 26-31 weeks was an independent risk factor for the birth of infants belonging to Block D (light placenta and balanced growth of infant), after adjusting for past history of either preeclampsia or gestational hypertension, high pulsatility index of uterine artery flow velocity waveforms in the second trimester, and serum level of PlGF.

CONCLUSIONS

Low PlGF levels at 26-31 weeks of gestation may precede a light placenta and relatively heavy infant (Block A), and high sEng levels at 26-31 weeks of gestation may precede a light placenta and balanced growth of infant (Block D).

摘要

目的

本研究旨在探讨孕 19-25 周和 26-31 周时血清胎盘生长因子(PlGF)和可溶性内皮糖蛋白(sEng)水平与胎盘重量(PW)和胎儿/胎盘比(F/P 比)的 9 块分类的发生是否相关。

方法

我们对 1391 例单胎妊娠女性进行了回顾性队列研究。采用酶联免疫吸附法测定血清 PlGF 和 sEng 水平。将胎盘重量 Z 评分(PW ZS)< -1.28 SD 定义为轻型胎盘。根据 PW(轻型、正常和重型)和 F/P 比(相对重型、平衡生长和相对小型)进行 9 块分类。采用多变量逻辑回归分析。

结果

校正孕前体重指数和 sEng 血清水平后,孕 26-31 周时 PlGF 水平较低是婴儿属于 A 块(轻型胎盘和相对重型婴儿)的独立危险因素。校正子痫前期或妊娠期高血压病史、中孕期子宫动脉血流速度搏动指数和 PlGF 血清水平后,孕 26-31 周时 sEng 水平较高是婴儿属于 D 块(轻型胎盘和平衡生长婴儿)的独立危险因素。

结论

孕 26-31 周时 PlGF 水平较低可能预示着轻型胎盘和相对重型婴儿(A 块),而孕 26-31 周时 sEng 水平较高可能预示着轻型胎盘和平衡生长婴儿(D 块)。

相似文献

1
Low placental growth factor levels and high soluble endoglin levels at 26-31 weeks of gestation precede light placenta with and without relatively heavy infant, respectively: A retrospective cohort study.低胎盘生长因子水平和高可溶性内皮糖蛋白水平在妊娠 26-31 周时分别预示着轻胎盘和伴有相对较重婴儿的轻胎盘:一项回顾性队列研究。
J Obstet Gynaecol Res. 2021 Mar;47(3):1040-1051. doi: 10.1111/jog.14636. Epub 2021 Jan 5.
2
Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.妊娠晚期母体血浆血管生成/抗血管生成因子水平识别接近足月或足月发生死胎及重度晚期子痫前期的高危患者。
Am J Obstet Gynecol. 2013 Apr;208(4):287.e1-287.e15. doi: 10.1016/j.ajog.2013.01.016. Epub 2013 Jan 17.
3
Independent risk factors for a small placenta and a small-for-gestational-age infant at 35-41 weeks of gestation: An association with circulating angiogenesis-related factor levels at 19-31 weeks of gestation.孕35 - 41周时胎盘小和小于胎龄儿的独立危险因素:与孕19 - 31周时循环血管生成相关因子水平的关联
J Obstet Gynaecol Res. 2017 Aug;43(8):1285-1292. doi: 10.1111/jog.13360. Epub 2017 Jun 14.
4
The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.利用母体血液中的血管生成生物标志物来识别哪些小于胎龄儿需要早产以及哪些母亲会发生先兆子痫。
J Matern Fetal Neonatal Med. 2016;29(8):1214-28. doi: 10.3109/14767058.2015.1048431.
5
Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.新型循环胎盘标志物促动力蛋白-1、可溶性fms样酪氨酸激酶-1、可溶性内皮糖蛋白和胎盘生长因子及其与晚期流产的关联
Hum Reprod. 2016 Dec;31(12):2681-2688. doi: 10.1093/humrep/dew225. Epub 2016 Sep 22.
6
The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).孕20 - 24周时通过简单的母体血液检测预测胎儿死亡:血管生成指数-1(胎盘生长因子/可溶性血管内皮生长因子受体-1比值)的作用
Am J Obstet Gynecol. 2017 Dec;217(6):682.e1-682.e13. doi: 10.1016/j.ajog.2017.10.001. Epub 2017 Oct 13.
7
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.一项关于孕早期和孕中期母体血浆血管生成因子和抗血管生成因子浓度在识别先兆子痫患者中的价值的前瞻性队列研究。
J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.
8
The Association of IL-17 and PlGF/sENG Ratio in Pre-Eclampsia and Adverse Pregnancy Outcomes.子痫前期中 IL-17 和 PlGF/sENG 比值与不良妊娠结局的关系。
Int J Environ Res Public Health. 2022 Dec 31;20(1):768. doi: 10.3390/ijerph20010768.
9
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.一项关于血管生成(胎盘生长因子)和抗血管生成(可溶性内皮糖蛋白和可溶性血管内皮生长因子受体-1)因子在正常妊娠以及注定会发生先兆子痫并分娩小于胎龄儿的患者中的纵向研究。
J Matern Fetal Neonatal Med. 2008 Jan;21(1):9-23. doi: 10.1080/14767050701830480.
10
Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.前瞻性研究子痫前期和妊娠期高血压前后胎盘血管生成因子与母体血管功能。
Circulation. 2010 Aug 3;122(5):478-87. doi: 10.1161/CIRCULATIONAHA.109.895458. Epub 2010 Jul 19.

引用本文的文献

1
Maternal angiogenic factor disruptions prior to clinical diagnosis of preeclampsia: insights from the REVAMP study.子痫前期临床诊断前的母体血管生成因子紊乱:来自 REVAMP 研究的见解。
Hypertens Res. 2024 Sep;47(9):2532-2548. doi: 10.1038/s41440-024-01775-8. Epub 2024 Jul 4.